Resultados de la búsqueda 151-160 of 11024 for sickle cell
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
Red blood cell count: An unrecognized risk factor for nonalcoholic fatty liver disease. Frontiers in Endocrinology. 2021; doi:10.3389/fendo.2021.760981 ...
Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...
... cell technology. It is hoped that the molecular, cellular, and electrophysiological phenotypes of these in-vitro disease models will further elucidate the ...
Chemotherapy drugs, such as cisplatin, carboplatin, and gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...
... cells (MSC), and bank them for future use. MelmarT Melanoma Margins ... Allogeneic Mesenchymal Stromal Cell Donor Bank. Rochester, Minn. The purpose ...
Allogeneic Mesenchymal Stromal Cell Donor Bank. Rochester, Minn. The purpose of this study is to collect adipose tissue from patients undergoing elective ...
Allogeneic Mesenchymal Stromal Cell Donor Bank. Rochester, Minn. The purpose ... cells (MSC), and bank them for future use. MelmarT Melanoma Margins ...
The purpose of this study is the growing and storage of stem cells, made using the tissue samples of patients and others. As new technologies develop, these ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?